Evaluation of the relationship between plasma concentrations of en- and zuclomiphene and induction of ovulation in anovulatory women being treated with clomiphene citrate

Fertility and Sterility

Volumn 91, Issue 4, 2009, Pages 1135-1140

  Ghobadi, Cyrus ^a   Amer, Saad ^a   Lashen, Hany ^a   Lennard, Martin S ^a   Ledger, William L ^a   Rostami Hodjegan, Amin ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Clomiphene citrate; clomiphene isomers; concentration response; infertility treatment; normogonadotropic anovulatory infertility; ovulatory response

Indexed keywords

CLOMIFENE CITRATE; ZUCLOMIFENE;

ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILITY; HUMAN; INFERTILITY; OUTCOME ASSESSMENT; OVULATION; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; ANOVULATION; BODY MASS INDEX; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; OVULATION; OVULATION INDUCTION; ROC CURVE; TIME FACTORS; YOUNG ADULT;

EID: 62949122648     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.01.058     Document Type: Article

References (34)

1. World Health Organization. WHO manual for the standardized investigation and diagnosis of the infertile couple (1993), Cambridge University Press, Cambridge, United Kingdom
2. The ESHRE Capri Workshop Group. Anovulatory infertility. Hum Reprod 10 (1995) 1549-1553
3. Lord J.M., Flight I.H., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327 (2003) 951-953
4. Palomba S., Orio Jr. F., and Zullo F. What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered. Gynecol Endocrinol 23 (2007) 245-247
5. Neveu N., Granger L., St-Michel P., and Lavoie H.B. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome. Fertil Steril 87 (2007) 113-120
6. Barbieri R.L. Clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is. J Clin Endocrinol Metab 92 (2007) 3399-3401
7. Palomba S., Orio Jr. F., Falbo A., Manguso F., Russo T., Cascella T., et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 (2005) 4068-4074
8. Holzer H., Casper R., and Tulandi T. A new era in ovulation induction. Fertil Steril 85 (2006) 277-284
9. Sturrock N.D., Lannon B., and Fay T.N. Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br J Clin Pharmacol 53 (2002) 469-473
10. Legro R.S., Barnhart H.X., Schlaff W.D., Carr B.R., Diamond M.P., Carson S.A., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007) 551-566
11. Moll E., Bossuyt P.M., Korevaar J.C., Lambalk C.B., and van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 332 (2006) 1485
12. Hughes E., Collins J., and Vandekerckhove P. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst Rev 2 (2000) CD000056
13. Imani B., Eijkemans M.J., Faessen G.H., Bouchard P., Giudice L.C., and Fauser B.C. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril 77 (2002) 83-90
14. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83 (1998) 2361-2365
15. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84 (1999) 1617-1622
16. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 77 (2002) 91-97
17. Dickey R.P., Taylor S.N., Curole D.N., Rye P.H., Lu P.Y., and Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Hum Reprod 12 (1997) 449-453
18. Ruenitz P.C. Rabbit liver microsomal metabolism of enclomiphene. Drug Metab Dispos 9 (1981) 456-460
19. Ruenitz P.C., Arrendale R.F., George G.D., Thompson C.B., Mokler C.M., and Nanavati N.T. Biotransformation of the antiestrogen clomiphene to chemically reactive metabolites in the immature female rat. Cancer Res 47 (1987) 4015-4019
20. Ruenitz P.C., Bagley J.R., and Mokler C.M. Metabolism of clomiphene in the rat. Estrogen receptor affinity and antiestrogenic activity of clomiphene metabolites. Biochem Pharmacol 32 (1983) 2941-2947
21. Rostami-Hodjegan A., Lennard M.S., Tucker G.T., and Ledger W.L. Monitoring plasma concentrations to individualize treatment with clomiphene citrate. Fertil Steril 81 (2004) 1187-1193
22. Ernst S., Hite G., Cantrell J.S., Richardson Jr. A., and Benson H.D. Stereochemistry of geometric isomers of clomiphene: a correction of the literature and a reexamination of structure-activity relationships. J Pharm Sci 65 (1976) 148-150
23. Tietz N.W. Clinical guide to laboratory tests (1995), W.B. Saunders, Philadelphia
24. Li T.C., Spuijbroek M.D., Tuckerman E., Anstie B., Loxley M., and Laird S. Endocrinological and endometrial factors in recurrent miscarriage. BJOG 107 (2000) 1471-1479
25. Crewe H.K., Ghobadi C., Gregory A., Rostami-Hodjegan A., and Lennard M.S. Determination by liquid chromatography-mass spectrometry of clomiphene isomers in the plasma of patients undergoing treatment for the induction of ovulation. J Chromatogr B Analyt Technol Biomed Life Sci 847 (2007) 296-299
26. Hopke P.K., Liu C., and Rubin D.B. Multiple imputation for multivariate data with missing and below-threshold measurements: time-series concentrations of pollutants in the Arctic. Biometrics 57 (2001) 22-33
27. Beal S.L. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 28 (2001) 481-504
28. Young S.L., Opsahl M.S., and Fritz M.A. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril 71 (1999) 639-644
29. Mikkelson T.J., Kroboth P.D., Cameron W.J., Dittert L.W., Chungi V., and Manberg P.J. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril 46 (1986) 392-396
30. Ghobadi C, Gregory A, Crewe HK, Rostami-Hodjegan A, Lennard MS. CYP2D6 is primarily responsible for the metabolism of clomiphene. Drug Metab Pharmacokinet. In press.
31. Goetz M.P., Knox S.K., Suman V.J., Rae J.M., Safgren S.L., Ames M.M., et al. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 101 (2007) 113-121
32. Beverage J.N., Sissung T.M., Sion A.M., Danesi R., and Figg W.D. CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci 96 (2007) 2224-2231
33. Crewe H.K., Ellis S.W., Lennard M.S., and Tucker G.T. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochem Pharmacol 53 (1997) 171-178
34. Dickinson G.L., Rezaee S., Proctor N.J., Lennard M.S., Tucker G.T., and Rostami-Hodjegan A. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application. J Clin Pharmacol 47 (2007) 175-186